 | Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 7.3%
americanbankingnews.com - June 14 at 2:06 PM |
| Aligos Therapeutics (NASDAQ:ALGS) Trading Down 7.3%
americanbankingnews.com - June 14 at 2:06 PM |
 | Aligos Therapeutics Announces Pipeline Update and Upcoming Presentations at the European Association for the Study of the Liver’s Digital International Liver Congress 2021
finance.yahoo.com - June 14 at 1:04 PM |
| Head-To-Head Contrast: Aligos Therapeutics (ALGS) & Its Rivals
americanbankingnews.com - June 13 at 1:08 PM |
| Aligos Therapeutics (ALGS) & Its Rivals Critical Analysis
americanbankingnews.com - June 12 at 9:22 AM |
| Aligos Therapeutics (NASDAQ:ALGS) Trading 7.4% Higher
americanbankingnews.com - June 11 at 1:44 PM |
| Aligos Therapeutics (NASDAQ:ALGS) Shares Gap Up to $29.89
americanbankingnews.com - June 10 at 12:36 PM |
| Aligos Therapeutics to Present Preliminary Antiviral Activity of ALG-000184 in Chronic Hepatitis B (CHB) Subjects at HBV-TAG Conference
finance.yahoo.com - June 10 at 8:29 AM |
| Head-To-Head Contrast: Aligos Therapeutics (ALGS) versus Its Competitors
americanbankingnews.com - June 7 at 7:14 AM |
| Aligos Therapeutics (NASDAQ:ALGS) Stock Price Up 4.9%
americanbankingnews.com - June 3 at 12:48 PM |
|
| Critical Comparison: Aligos Therapeutics (ALGS) & The Competition
americanbankingnews.com - June 3 at 11:24 AM |
| Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 6%
americanbankingnews.com - June 2 at 2:44 PM |
 | NASH crash hits another Bay Area 'fatty liver' drug hopeful
bizjournals.com - May 24 at 6:04 PM |
| Aligos Therapeutics to Present at the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 20 at 6:38 PM |
| Aligos Therapeutics Reports Recent Business Progress and First Quarter 2021 Financial Results
finance.yahoo.com - May 10 at 9:02 PM |
| Aligos Therapeutics to Announce First Quarter 2021 Results May 10, 2021
finance.yahoo.com - May 5 at 12:11 PM |
| Aligos Therapeutics Appoints James Scopa, J.D., MBA, to its Board of Directors
finance.yahoo.com - April 27 at 7:16 PM |
| Aligos Therapeutics Begins Dosing with Capsid Assembly Modulator Drug Candidate, ALG-000184, in First Cohort of Chronic Hepatitis B Patients in a Phase 1 Proof-of-Concept Study
finance.yahoo.com - April 14 at 8:09 AM |
 | Here's Why We're Not Too Worried About Aligos Therapeutics' (NASDAQ:ALGS) Cash Burn Situation
nasdaq.com - April 6 at 6:47 PM |
| Aligos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 23 at 6:33 PM |
| Aligos Therapeutics Begins Dosing with STOPS™ Molecule Drug Candidate, ALG-010133, in First Cohort of Chronic Hepatitis B Patients in a Phase 1 Proof-of-Concept Study
finance.yahoo.com - March 10 at 9:00 AM |
| Aligos Therapeutics Presents Nonclinical Data for its COVID-19 Therapeutic in Development at the 2021 Conference on Retroviruses and Opportunistic Infections
finance.yahoo.com - March 8 at 9:29 AM |
| Aligos Therapeutics Presents Data for its Chronic Hepatitis B Drug Candidates at the 30th Annual Conference of the Asian Pacific Association for the Study of the Liver
finance.yahoo.com - February 3 at 8:14 AM |
| Do Insiders Own Lots Of Shares In Aligos Therapeutics, Inc. (NASDAQ:ALGS)?
finance.yahoo.com - January 16 at 9:21 AM |
| Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 9:39 AM |
| Aligos (ALGS) in Focus: Stock Moves 5.6% Higher
nasdaq.com - December 17 at 12:22 PM |
| Aligos Therapeutics Presents Update on Development of SARS-CoV-2 Therapeutic Candidate and Screening Method in Collaboration with KU Leuven at RespiDART & Emerging Viruses 2020
finance.yahoo.com - December 17 at 12:22 PM |
| Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
finance.yahoo.com - December 7 at 9:28 AM |
|
| Aligos Therapeutics, Inc. Common Stock (ALGS)
nasdaq.com - December 5 at 1:26 AM |
 | Aligos Therapeutics Inc.
barrons.com - November 23 at 6:10 PM |
| Time to Make a Move? J.P. Morgan Offers 3 Stocks to Buy
finance.yahoo.com - November 18 at 1:42 PM |
| Aligos Therapeutics Presents Data on Chronic Hepatitis B, NASH and Hepatocellular Carcinoma Programs at AASLD’s The Liver Meeting Digital Experience™ 2020
finance.yahoo.com - November 16 at 9:13 AM |
 | Aligos Therapeutics is awarded EUR1.8M VLAIO grant to advance chronic hepatitis B research
marketwatch.com - November 13 at 10:00 AM |
| Aligos Therapeutics Announces Presentations at the Jefferies Virtual London Healthcare Conference & the Piper Sandler Annual Healthcare Conference
finance.yahoo.com - November 13 at 10:00 AM |
 | Aligos Therapeutics secures €1.8M grant to advance hepatitis B research
seekingalpha.com - November 12 at 1:45 PM |
| Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
finance.yahoo.com - November 12 at 8:44 AM |
| Dosing underway for Aligos Therapeutics' hepatitis B candidate in early-stage study
seekingalpha.com - October 30 at 11:56 AM |
| Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B
finance.yahoo.com - October 30 at 11:56 AM |
| Foghorn Therapeutics, the Latest Biotech to Go Public, Rises 13% in Its Market Debut
barrons.com - October 23 at 11:03 PM |
| There’s an IPO Party in Biotech. Praxis Precision Led Friday’s Slate With a 62% Pop.
finance.yahoo.com - October 23 at 7:57 AM |
| Hearing-Aid Maker Eargo Soars 87% in Its First Trading Day
finance.yahoo.com - October 23 at 7:57 AM |
